Clinical Trial Update: Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating hyoscine butylbromide for preventing bradycardia during cesarean section under spinal anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia
• Cesarean Section Complications
• Spinal Anesthesia Adverse Effects

Drugs mentioned

• Hyoscine Butylbromide (hyoscine butylbromide)

Snippet

Sponsor: Assiut University | Conditions: Bradycardia, Spinal Anesthetics Causing Adverse Effects in Therapeutic Use | Phase 4 | Status: COMPLETED